Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125519001 | 12551900 | 1 | I | 20110601 | 0 | 20160712 | 20160712 | DIR | 67.00 | YR | F | N | 205.00000 | LBS | 20160711 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125519001 | 12551900 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | Y | Y | MD2386 | 20160630 | 0 | 1 | DF | COATED TABLET | QD | |||
| 125519001 | 12551900 | 2 | SS | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | Y | D | 20170307 | 0 | 1 | DF | COATED TABLET | HS | ||||
| 125519001 | 12551900 | 4 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 125519001 | 12551900 | 6 | C | CHLORITHALIDONE | 2 | 0 | |||||||||||||
| 125519001 | 12551900 | 8 | C | POTA CHLORIDE | 2 | 0 | |||||||||||||
| 125519001 | 12551900 | 10 | C | ONDANSETRON | ONDANSETRON | 1 | 0 | ||||||||||||
| 125519001 | 12551900 | 12 | C | ESTROVAN | 2 | 0 | |||||||||||||
| 125519001 | 12551900 | 14 | C | Z-BEC B-COMPLEX | 2 | 0 | |||||||||||||
| 125519001 | 12551900 | 16 | C | GLUCOSAMINE CHONDROITIN | CHONDROITIN SULFATE (BOVINE)GLUCOSAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125519001 | 12551900 | 18 | C | CELERY SEED | CELERY SEED | 1 | 0 | ||||||||||||
| 125519001 | 12551900 | 20 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 125519001 | 12551900 | 22 | C | BIOTIN | BIOTIN | 1 | 0 | ||||||||||||
| 125519001 | 12551900 | 24 | C | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 125519001 | 12551900 | 26 | C | COQ10 | UBIDECARENONE | 1 | 0 | ||||||||||||
| 125519001 | 12551900 | 28 | C | SUPPER B-COMPLEX | 2 | 0 | |||||||||||||
| 125519001 | 12551900 | 30 | C | TUMERIC | TURMERIC | 1 | 0 | ||||||||||||
| 125519001 | 12551900 | 32 | C | ASPIRIN. | ASPIRIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125519001 | 12551900 | 1 | Blood cholesterol increased |
| 125519001 | 12551900 | 2 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125519001 | 12551900 | OT |
| 125519001 | 12551900 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125519001 | 12551900 | Diarrhoea | |
| 125519001 | 12551900 | Gluten sensitivity | |
| 125519001 | 12551900 | Heart rate increased | |
| 125519001 | 12551900 | Hyperhidrosis | |
| 125519001 | 12551900 | Syncope | |
| 125519001 | 12551900 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125519001 | 12551900 | 1 | 11 | YR | ||
| 125519001 | 12551900 | 2 | 20110601 | 20160708 | 0 |